Eupraxia Pharmaceuticals, Inc. · TSX:EPRX
MORGAN C. FRANK reported a 9.20% stake in Eupraxia Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
MORGAN C. FRANK reported a 9.20% stake in Eupraxia Pharmaceuticals, Inc., 4,904,523 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.20%
- Shares
- 4,904,523
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MANCHESTER MANAGEMENT COMPANY, LLC | 8.80% | 4,720,144 |
| MANCHESTER MANAGEMENT PR, LLC | 8.80% | 4,720,144 |
| MANCHESTER EXPLORER, L.P | 8.60% | 4,597,217 |
| JAMES E. BESSER | 9.10% | 4,858,437 |
| MORGAN C. FRANK | 9.20% | 4,904,523 |
Source
Related
- Eupraxia Pharmaceuticals, Inc.
- James E. Besser
- Eupraxia Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · James E. Besser · Aug 13, 2026
- Schedule 13G/A · James E. Besser · May 12, 2026
- Schedule 13G · James E. Besser · Nov 13, 2025
- Schedule 13D/A · Joseph S. Freedman · Mar 16, 2026
- Schedule 13G/A · Robert Disbrow · Nov 14, 2025
- Schedule 13G · Beutel, Goodman & Co Ltd. · Nov 14, 2025
- Schedule 13D/A · Joseph S. Freedman · Sep 26, 2025